ascendis pharma glp-1 receptor agonist weight management diabetes treatments Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Upcoming wave of hormone-based therapies
Description
Rizzoli, Genve (Ostoporose)
Mol Metab 5 , 834843, (2016)
While they share a common mechanismmimicking the GLP-1 hormone to stimulate insulin secretion, suppress glucagon release, and slow gastric emptyingthey differ in their molecular structures, dosing schedules, efficacy, and side effect profiles
Diabetol Metab Syndr 17 , 179 (2025)
Statistical Analysis Continuous variables are presented as mean (SD), and categorical variables are presented as number (%)
